Tag: EuroPCR 2018
“Wait-and-see” is not an option with the new device regulations
The new EU Medical Device Regulation (MDR) was officially published on 5 May 2017 and entered in...
EuroPCR 2018: Study indicates “almost perfect agreement” between CT angiography and conventional angiography for revascularisation decisions
A new study, SYNTAX III REVOLUTION, has found heart teams using computed tomography (CT) angiogr...
EuroPCR 2018: Both immediate and delayed approaches seem to work for transient STEMI patients
A new study indicates that a delayed approach in patients with transient ST-segment elevation my...
EuroPCR 2018: Will SPYRAL-ON change my practice?
In this PCR video, David E Kandzari (Department of Interventional Cardiology, Piedmont Heart Institu...
EuroPCR 2018: Low incidence of cardiovascular mortality with Centera self-expanding valve at one year
Hermann Reichenspurner (Departments of Cardiovascular Surgery and General and Interventional Car...
EuroPCR 2018: No significant difference in bioprosthetic valve dysfunction between surgical and TAVI devices at six years
The NOTION trial (Nordic aortic valve intervention) was the first comparison of surgical and tra...
EuroPCR 2018: Real-world data confirm trial outcomes for Sapien 3
Thirty-day data presented at EuroPCR (22 May—25 May, Paris, France) show consistently positive p...
EuroPCR 2018: FFR-guided PCI reduces spontaneous myocardial infarction
Five-year data from FAME (Fractional Flow Reserve vs. Angioplasty for Multivessel Evaluation) 2 ...
EuroPCR 2018: New ORBITA analysis finds iFR/FFR values do not predict impact of PCI on exercise time
New data from the ORBITA trial indicates percutaneous coronary intervention (PCI) does not signi...
EuroPCR 2018: Data confirms long-term safety and efficacy of Angiolite drug-eluting stent
At EuroPCR (22 May–25 May, Paris, France), the 12-month results of the ANGIOLITE trial were pres...
EuroPCR 2018: PiCSO therapy reduces infarct size in acute myocardial infarction patients
The clinical results from the OxAMI-PiCSO study—published in EuroIntervention and presented at E...
EuroPCR 2018: Interim nine-month results for Magnitude presented
Amaranth Medical provided an update on its sirolimus-eluting bioresorbable scaffold products during ...
Positive clinical results from eCOBRA study
CeloNova BioSciences has announced one-year clinical trial results from the eCOBRA post-market s...
EuroPCR 2018: One- to two-year landmark analysis shows significantly lower target lesion failure with Orsiro vs. Resolute Integrity
Two-year outcome data from the BIO-RESORT randomised controlled trial, which were presented in a...
EuroPCR 2018: DIAB8 randomised study to compare Cre8 Evo with everolimus-eluting stents in diabetic patients
Alvimedica unveiled the details of the Diab8 study—the first diabetic drug-eluting stent randomised ...
EuroPCR 2018: Further evidence for safety and efficacy of Magmaris bioresorbable scaffold
Data presented during EuroPCR (22 May – 25 May, Paris, France) provide further evidence on its c...
EuroPCR 2018: Positive data for renal denervation reignites interest in field
After two studies indicated that renal denervation lowers blood pressure both with and without a...
EuroPCR 2018: Two studies provide support for HeartFlow Analysis
New data from the PACIFIC study presented at EuroPCR (22 May – 25 May, Paris, France) showed that th...
EuroPCR 2018: Boston Scientific outlines its key presentations
Boston Scientific Corporation has revealed its schedule of key presentations—including two late-...
EuroPCR 2018: First-in-human study of Leaflex Performer for aortic stenosis initiated
Pi-Cardia has recently started its first-in-human study with its Leaflex Performer catheter system. ...
New trial of Symplicity Spyral approved
Medtronic has announced US FDA approval to begin an investigational device exemption (IDE) pivot...
